Atlas Trials

Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C

Clinical trial NCT01577758 · COMPLETED

Trial details

NCT number
NCT01577758
Sponsor
Millennium Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Gastrointestinal Malignancies
Start date
2012-06-01
Primary completion
2014-02-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.